Home Home
  • contact us
  • read our blog
  • view cart
  • my account
country list image   
  • Products  
    • Promotions
    • Primary Antibodies
    • Secondary Antibodies
    • Antibody Pairs
    • Antibody Packs
    • Lysates
    • Peptides and Proteins
    • Kits
    • RNAi
    • Slides
    • Isotype Controls
    • Support Products
    • Precipitor
    • Explorer
    • All Research Reagents
  • Research Areas  
  • Support  
    • Novus Guarantee
    • Technical Support
    • Customer Service
    • Help Finding Antibodies
    • Protocols
    • Antibody Guides
    • Custom Antibody Labeling
    • How To Teaching Series
    • Request Literature
  • Distributors  
  • About  
    • Contact Us
    • Novus Story
    • Novus Team
    • Novus Philanthropy
    • Rewards Program
    • Newsletters
    • Press Releases
    • Novus Events
    • Collaborations
    • Careers at Novus
Home
 

Apoptosis eNews - 1st Edition

Apoptosis eNews - 1st Edition Tue, 2009-09-29

Summary: 
Read up on the latest news in apoptosis research. This edition contains a list of Novus' apoptosis sale products, new apoptosis publications and an editorial spotlight on Bcl-2.
Date: 
Tue, 2009-09-29

APOPTOSIS NEWSLETTER - 1st Edition

Spotlight on Bcl-2
Bcl-2 suppresses apoptsois by controlling mitochondrial membrane permeability and inhibiting caspase activity by forming pores in the mitochondrial outer membrane.  Despite Bcl-2’s known role in the mitochondrial mediated pathway of apoptosis, it is unknown whether Bcl-2 forms monomeric or oligomeric pores.  A recent study shows that the Bcl-2 pore expands as the concentration of Bcl-2 increases, thus suggesting that the pore is formed by Bcl-2 oligomers (Peng J, et al. Apoptosis. 2009;14(10):1145-53).  Bcl-2 formed pores are much smaller than the pores created via Bax action, therefore the oligomerization findings in this study support the model that Bcl-2 is a defective Bax.

Bcl-2 Antibodies:

Georgetown University


Cytochrome c

Bcl-2 [Ser70] Antibody – NBP1-02683

Georgetown University


Cytochrome c

Bcl-2 (BCL/10C4) Antibody – NB100-78543
Georgetown University


Cytochrome c

Bcl-2 Antibody – NB100-78342
Georgetown University


Cytochrome c

Bcl-2 [Thr56] Antibody – NBP1-02865

Want to learn more about Apoptosis?
Sign up to receive a copy of Novus’ Apoptosis Product Catalog.

Coming Soon: Customer Reviews Published on our Website

IRE-1 Alpha Phosphospecific Antibody [NB100-2323]

star review


Cytochrome c

NB100-2323 was given 5 stars in a customer review submitted on May 27, 2009. The customer conducted Western blot analysis on mouse lens tissue at a dilution of 1:1,000. A specific band was visualized at 110 kDa.

New Product Information
25% OFF select apoptosis-related antibodies and proteins. View the list here.

Publications
[cIAP2 NBP1-27972]  Bertrand MJ, et al. Cellular inhibitors of apoptosis cIAP1 and cIAP2 are required for innate immunity signaling by the pattern recognition receptors NOD1 and NOD2. Immunity. 2009 Jun;30(6):789-801. [PMID: 19464198]

[IRE-1 alpha NB100-2323] Kashiwakura Y, et al. Down-regulation of inhibition of differentiation-1 via activation of activating transcription factor 3 and smad regulates REIC/Dickkopf-3-Induced apoptosis. Cancer Res. 2008 Oct;68(20):8333-8341. [PMID: 18922905]

[PERP NB500-231] Singaravelu K, et al. PERP, a p53 proapoptotic target, mediates apoptotic cell death in renal ischemia. Am J Physiol Renal Physiol. 2009 Apr;296(4):F847-858 [PMID: 19158346]

[Survivin NB500-201]  Song KY, et al. Expression of the antiapoptosis gene survivin predicts poor prognosis of stage III gastric adenocarcinoma. Jpn J Clin Oncol. 2009 May;39(5):290-296. [PMID: 19336448]

[TRAIL NB500-220] Herzer K, Hofmann TG, Teufel A, et al. IFN-alpha-induced apoptosis in hepatocellular carcinoma involves promyelocytic leukemia protein and TRAIL independently of p53. Cancer Res. 2009 Feb;69(3):855-862. [PMID: 19141642]

Georgetown University


Cytochrome c

 

 

Share    
Privacy Policy | Contact Us | Sitemap | XML
©2011 Novus Biologicals. All Rights Reserved.
  |  
  |